It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Depression Medication Treatment Study

Clinical Trial Title: 
Depression medication treatment study.
Clinical Trial Protocol ID: 
15012204
Clinical Trial Investigator Name: 
Corey N. Goldstein, MD
Clinical Trial Protocol Description: 

This is a study of an FDA-approved medication for depression to see how effective it is in preventing a return of symptoms after the depression has been successfully treated. 

This is a 48-week study. During the first 16 weeks all participants receive the study drug. Those whose depression improves may continue in the next 32-week phase during which some subjects will receive placebo and some will continue on the study drug.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Be 18-75 years of age.
  • Have major depressive disorder.

You will be excluded from the study if any of the following criteria apply to you:

  • Have certain other diagnoses.
  • Have a history of ECT and/or certain other treatments or procedures within 6 months of study.
  • Have current, or history of, substance use or dependence.
  • Have certain other medical conditions or are required to take a medication that is excluded during the study.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Mental Health Disorders
Contact Phone: 
(312) 942-6597
Contact Name: 
Treatment Research Center